Tuesday, 11 October 2016

Biotech startup Zymergen nabs $130 million from Softbank

photography by Albert Law : http://ift.tt/1kqHThs Zymergen, a Bay Area startup creating all sorts of materials from genetically altered microbes, just raised $130 million in Series B funding from Softbank. For those unfamiliar, the company makes crazy new materials out of genetically alter microbes. It was busy buying up a bunch of robots to make these microbes for mass production of various materials during its last round of funding. CEO… Read More
Share:

0 comments:

Post a Comment